Evidence map›Paper›PMID 28058717›Full record

ArticleEuropean journal of immunology2017

Deletional tolerance prevents AQP4-directed autoimmunity in mice.

Anna-Lena Vogel, Benjamin Knier, Katja Lammens, Sudhakar Reddy Kalluri, Tanja Kuhlmann, Jeffrey L Bennett, Thomas Korn

Open access · hybridAbstract read
In one paragraph

Article in European journal of immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. MOGJournal of neuroinflammation · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Gut Microbiome in Neuromyelitis Optica.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Anna-Lena VogelKlinikum rechts der Isar, Department of Neurology, Technical University of Munich, Munich, Germany.
Benjamin KnierKlinikum rechts der Isar, Department of Neurology, Technical University of Munich, Munich, Germany.
Katja LammensDepartment of Biochemistry at the Gene Center, Ludwig-Maximilians-University, Munich, Germany.
Sudhakar Reddy KalluriKlinikum rechts der Isar, Department of Neurology, Technical University of Munich, Munich, Germany.
Tanja KuhlmannInstitute of Neuropathology, University Hospital Münster, Münster, Germany.
Jeffrey L BennettDepartment of Neurology, School of Medicine, University of Colorado, Aurora, CO, USA.
Thomas KornKlinikum rechts der Isar, Department of Neurology, Technical University of Munich, Munich, Germany.ORCID 0000-0002-3633-0955
TUM Klinikum · DELudwig-Maximilians-Universität München · DEUniversity Hospital Münster · DEUniversity of Colorado Anschutz Medical Campus · US

Funding

Autoimmunity Center of Excellence Clinical Research ProgramUM1AI110498 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOFSY, DAVID · 2014 to 2019
$31.4M
Humoral Immunity, Astrocyte Injury, and Demyelination in Neuromyelitis OpticaR01EY022936 · NEI · UNIVERSITY OF COLORADO DENVER · PI BENNETT, JEFFREY L · 2013 to 2022
$3.8M
Colorado Autoimmunity Center of ExcellenceUM1AI110503 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 2014 to 2018
$543k
European Research Council 647215NEI NIH HHS R01 EY022936NIAID NIH HHS UM1 AI110498NIAID NIH HHS UM1 AI110503
6 · The paper itself

Abstract

Neuromyelitis optica (NMO) is an autoimmune disorder of the central nervous system (CNS) mediated by antibodies to the water channel protein AQP4 expressed in astrocytes. The contribution of AQP4-specific T cells to the class switch recombination of pathogenic AQP4-specific antibodies and the inflammation of the blood-brain barrier is incompletely understood, as immunogenic naturally processed T-cell epitopes of AQP4 are unknown. By immunizing Aqp4

Indexed as

AnimalsAquaporin 4AstrocytesAutoantibodiesAutoimmunityB-LymphocytesClonal DeletionClone CellsEpitope MappingHistocompatibility Antigens Class IIHumansImmunodominant EpitopesImmunoglobulin Class SwitchingMiceMice, Inbred C57BLMice, KnockoutAqp4 protein, mouseAquaporin 4AutoantibodiesHistocompatibility Antigens Class III-A(b) antigen, mouseImmunodominant EpitopesMyelin-Oligodendrocyte Glycoproteinmyelin oligodendrocyte glycoprotein (35-55)Peptide FragmentsReceptors, Antigen, T-CellAquaporin 4 (AQP4)B cellEncephalitogenic epitopeExperimental neuromyelitis opticaOptical coherence tomographyT cellTolerance

Identifiers

PMID28058717
PMCPMC5359142
OpenAlexW2570467914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.